The Science of Pharmaceutical Compounding: Technician Training - Home Study

This knowledge-based activity will provide compounding technicians with the necessary skills for the safe handling of non-hazardous and hazardous drugs while preparing non-sterile dosage forms. Activity content surrounding relevant law, regulatory guidelines, and standards of practice is subdivided into a unique system, referred to as System P, which includes the following divisions: Personnel, Property, Procedure, Process, Preparation, and Patient. This section of the activity places emphasis on quality assurance and quality control through the implementation of standard operating procedures.

The activity engages the technician to understand the concept of compounding by composition (an in-depth look at the chemistry of solutions and dispersions in the form of suspensions and emulsions) and then apply this concept to the compounding of solid, semi-solid, and liquid dosage forms. Preparatory procedures are then related to the combination of route of delivery, dosage form, preparatory state-of-matter, and the final state-of-matter of the compounded medication. Finally, there is an exploration in excipient selection, function, and application in relation to composition, dosage form, and route of delivery.

Pharmaceutical calculations are presented in detail, providing a required level of quality control and quality management during the compounding process. Finally, the participant is introduced to process development, which leads to the establishment of pharmacy practice-specific master formulation records. A master formulation record template is also introduced and serves equally well as a process development record and compounding record that can be implemented in everyday practice.


Intended audience


Technicians new to non-sterile compounding.


Learning Assessment:

Please make sure to complete the home study learning assessment within 60 days of purchase. If this is not possible, please contact the LP3 Network Team.


Learning Objectives

FOR TECHNICIANS:
  1. Recall standard operating procedures associated with the management and safe handling of non-hazardous and hazardous drug compounding as indicated in the United States Pharmacopeia, covering Chapter <795> and related chapters.
  2. Relate dosage form chemical composition (solutions and dispersions; suspensions and emulsions), routes of delivery, and delivery systems to preparatory procedures for non-sterile compounded medications.
  3. Recognize the relevance of excipients and their function(s) related to chemical composition, routes of delivery, and delivery systems.
  4. Repeat pharmaceutical calculations, in support of a performance checking system between pharmacist and technician, related to specific dosage forms and preparatory procedures.
  5. Repeat laboratory practices, procedures, and preparatory techniques related to the day-to-day activities of a compounding technician, and to the compounding of non-sterile dosage forms.
  6. Recognize the importance of deactivation, decontamination, disinfection, and cleaning procedures for non-hazardous and hazardous drug compounding.
  7. State the use of personal protective equipment for non-hazardous and hazardous drug compounding.
  8. Recall general personnel roles and responsibilities, including medical surveillance and a hazardous drug management information program.
  9. Repeat written procedures related to process development documents that lead to the establishment of a master formulation record.
  10. List the requirements of a master formulation record and compounding record.

Editors

NEIL COHEN, BSc
CE Program Developer
Disclosure: MEDISCA, Consultant

DAPHNEE LALONDE, BSc, MSc
Continuing Education Supervisor
Disclosure: MEDISCA, Consultant



CONTRIBUTORS:

MARK FILOSI, BS Pharm, RPh
Compounding Pharmacist and Co-Founder, Family Care Pharmacy
Disclosure: Accreditation Commission for Health Care, Surveyor; MEDISCA, Consultant

JOE CABALEIRO, BS Pharm, RPh
Senior Associate, Gates Healthcare Associates
Disclosure: Accreditation Commission for Health Care, Consultant; Gates Healthcare Associates, Consultant; Healthrx Group, Consultant; MEDISCA, Consultant


Financial support: 


An unrestricted educational grant has been provided by MEDISCA Inc.


 

Course summary
Available credit: 
  • 2.00 CEU (ACPE)
  • 20.00 Contact Hours
Cost:
$350.00

Total CPE Credits (home study): 20 CPE Hours = 2.0 CEUs
Joint Providership Status (CPE Consultants, LLC / LP3 Network)

Home study activity type: Knowledge-based
Home study UAN: 0864-9999-18-050-H07-T for technicians
Home study CPE credits: 20 CPE hours = 2.0 CEUs
Release date: April 21, 2018
Expiration date: April 21, 2021

To receive CPE credits for the home study, participants must complete a learning assessment with a score of 70% and submit a completed evaluation.

accreditorCPE Consultants, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Accreditation Period

Course opens: 
01/01/2016
Course expires: 
01/01/2019

Price

Cost:
$350.00
Please login to Enroll or Add to Waitlist
Cancellation and refund policy: 


There are no refunds, returns, or transfers upon purchase of the home study.